Patient-assessed health outcomes in chronic lung disease what are they, how do they help us, and where do we go from here?

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 4 PART I, 1997, Pages 1032-1039

  Curtis, J Randall ^a   Martin, Diane P ^b   Martin, Thomas R ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

CHRONIC DISEASE; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; LUNG DISEASES; QUALITY OF LIFE; SOCIETIES, MEDICAL; UNITED STATES;

EID: 0030798771     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.4.97-02011     Document Type: Article

References (15)

1. Prigatano, G. P., E. C. Wright, and D. Levin. 1984. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch. Intern. Med. 144:1613-1619.
2. McSweeney, A. J., I. Grant, R. K. Heaton, K. M. Adams, and R. M. Timms. 1982. Life quality of patients with chronic obstructive pulmonary disease. Arch. Intern. Med. 142:473-478.
3. Juniper, E. F., P. R. Johnston, C. M. Borkhoff, G. H. Guyatt, L.-P. Boulett, and A. Houkioja. 1995. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am. J. Respir. Crit. Care Med. 151:66-70.
4. Noonan, M., P. Chervinsky, W. W. Busse, S. C. Weisberg, and J. Pinnas. 1995. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am. J. Respir. Crit. Care Med. 152:1467-1473.
5. Rutten van Molken, M. P., F. Custers, E. K. van Doorslaer, et al. 1995. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur. Respir. J. 8:888-898.
6. Jones, P. W., and Group at NSQoLS. 1994. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Eur. Respir. J. 7:55-62.
7. Orenstein, D. M., P. A. Nixon, E. A. Ross, and R. M. Kaplan. 1989. The quality of well being in cystic fibrosis. Chest 95:344-347.
8. Congleton, J., M. E. Hudson, and F. Duncan-Skingle. 1996. Quality of life in adults with cystic fibrosis. Thorax 51:936-940.
9. Barst, R. J., L. J. Rubin, W. A. Walker, et al. 1996. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N. Engl. J. Med. 334:296-301.
10. Jones, P. W. 1995. Quality of life measurement in asthma. Eur. Respir. J. 8:885-887.
11. Richards, J. M., Jr., and M. P. Hemstreet. 1994. Measures of life quality, role performance, and functional status in asthma research. Am. J. Respir. Crit. Care Med. 149:531-539.
12. Curtis, J. R., R. A. Deyo, and L. D. Hudson. 1994. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 49:162-170.
13. Guyatt, G. H., M. Townsend, S. O. Pugsley, et al. 1987. Bronchodilators in chronic air-flow limitation: effect on airway function, exercise capacity, and quality of life. Am. Rev. Respir. Dis. 135:1069-1074.
14. Mahler, D. A., R. A. Matthay, P. E. Snyder, C. K. Wells, and J. Loke. 1985. Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. Am. Rev. Respir. Dis. 131:22-25.
15. Wijkstra, P. J., E. M. Ten Vergert, R. van Altena, V. Otten, and Kraan. 1995. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax 50:824-828.